FDA Expands Sunscreen Options for the First Time in 20 Years
The FDA has added bemotrizinol to the list of permitted sunscreen active ingredients, the first such expansion in approximately 20 years.
This update affects manufacturers of sunscreen products, regulatory professionals overseeing over-the-counter (OTC) drug compliance, and formulation scientists in the personal care sector.
The inclusion of a new active ingredient suggests a shift in the regulatory landscape for sunscreens, which has seen little change in permitted UV filters for decades. For regulatory teams, this likely necessitates a review of existing product portfolios and future submission strategies to incorporate bemotrizinol. This development may imply an opening for further innovation in a category that has historically faced rigid ingredient limitations.
Regulatory teams should evaluate the technical specifications for bemotrizinol inclusion in upcoming OTC monographs or filings. R&D departments should assess formulation compatibility with this newly permitted active ingredient. Compliance officers should monitor for updated labeling requirements associated with its use.
Today, the U.S. Food and Drug Administration added bemotrizinol to the list of permitted sunscreen active ingredients, marking a significant milestone in the agency's efforts to advance sunscreen innovation.
Open in openFDA / FDA.gov